Memo

Keyphrases

Publications

volume 17, number 1, 2024

Stephan Brönimann, Nirmish Singla, Stephan M Korn, Nicolai A Huebner, Shahrokh F Shariat
Evidence and emerging trends in local therapy for metastatic hormone-sensitive prostate cancer: a narrative review. Memo 17 (1) (2024)
Stephan Brönimann, Nirmish Singla, Stephan M Korn, Nicolai A Huebner, Shahrokh F Shariat
Evidence and emerging trends in local therapy for metastatic hormone-sensitive prostate cancer: a narrative review. Memo 17 (1) (2024)

2023

Waltraud Elisabeth Huf, Arschang Valipour
Vaccination against SARS-CoV-2 in adults with a diagnosis of cancer: a short review. Memo (2023)
Waltraud Elisabeth Huf, Arschang Valipour
Vaccination against SARS-CoV-2 in adults with a diagnosis of cancer: a short review. Memo (2023)

volume 16, number 1, 2023

Waltraud Elisabeth Huf, Arschang Valipour
Vaccination against SARS-CoV-2 in adults with a diagnosis of cancer: a short review. Memo 16 (1) (2023)
Katharina Theresa Prochazka
Best of hematology-2021. Memo 16 (1) (2023)
Ewald Wöll
Austrian Society for Hematology and Medical Oncology (OeGHO) spring meeting 2023. Memo 16 (1) (2023)
Katharina Theresa Prochazka
Best of hematology-2021. Memo 16 (1) (2023)

volume 15, number 2, 2022

Jan-Paul Bohn
Agony of choice-selecting chronic lymphocytic leukemia treatment in 2022. Memo 15 (2) (2022)
Ahmed H Al Sharie, Yazan O Al Zu'bi, Sarah Al Sharie, Hawra A Baydoun, Farah H Atawneh, Osama Alshari, Dima Albals
Systemic capillary leak syndrome following granulocyte colony-stimulating factor therapy in a T-lymphoblastic leukemia/lymphoma patient: a case report. Memo 15 (2) (2022)
Christoph Suppan
ESMO 2021-my top three abstracts in breast cancer. Memo 15 (2) (2022)
Andreas Feichtner, Valentina Kugler, Selina Schwaighofer, Thomas Nuener, Jakob Fleischmann, Eduard Stefan
Tracking mutation and drug-driven alterations of oncokinase conformations. Memo 15 (2) (2022)
Lukas Weiss
ESMO 2021-highlights in colorectal cancer. Memo 15 (2) (2022)
Rupert Bartsch, Wolfgang Hilbe
COVID-19 crisis and cancer. Memo 15 (2) (2022)
Clemens A Schmitt
COVID-19: New disease mechanism is simultaneously a therapeutic target. Memo 15 (2) (2022)

volume 15, number 4, 2022

Andreas Petzer
ASCO update-best of the best. Memo 15 (4) (2022)
Andreas Petzer
ASCO update-best of the best. Memo 15 (4) (2022)

2021

Holger Rumpold
Lethal human metavirus pneumonia in a patient with chronic lymphocytic leukemia. Memo (2021)
Rupert Bartsch
ASCO 2020: highlights in breast cancer. Memo (2021)
Michael Fillitz, Barbara Dixer, Felix Keil
Practical considerations for the management of immune thrombocytopenic purpura. Memo (2021)
Lena Horvath, Andreas Pircher
ASCO 2020 non-small lung cancer (NSCLC) personal highlights. Memo (2021)
Rupert Bartsch
ESMO 2020: highlights in breast cancer. Memo (2021)
Rupert Bartsch
SABCS 2020: update on triple-negative and metastatic HER2-positive breast cancer. Memo (2021)
Josia Fauser, Stefan Köck, Eberhard Gunsilius, Andreas Chott, Andreas Peer, Adelheid Ditlbacher, Gernot Fritsche, Michael Joannidis, Dominik Wolf, Andreas Pircher
Death of unknown cause? Post-mortem diagnosis of fulminant course of an EBV-associated secondary hemophagocytic lymphohistiocytosis. Memo (2021)
Maher Salamoon, Mazen Kenj
Hemophagocytic lymphohistocytosis in a COVID-19 patient in the acute phase: case report. Memo (2021)
Katharina T Prochazka, Peter Neumeister
Chronic lymphocytic leukaemia-what is new and notable in 2021, with a special focus on COVID-19. Memo (2021)

volume 15, number 1, 2021

Pınar Cömert, Murat Albayrak, Mesut Tığlıoğlu, Hacer Berna Afacan Öztürk, Merih Reis Aras, Buğra Sağlam, Senem Maral
The outcome of COVID-19 in patients with hematological malignancy. Memo 15 (1) (2021)

volume 14, number 1, 2021

Christine Marosi
Elderly patients with cancer. Memo 14 (1) (2021)

volume 14, number 2, 2021

Öykü Umut, Adrian Gottschlich, Stefan Endres, Sebastian Kobold
CAR T cell therapy in solid tumors: a short review. Memo 14 (2) (2021)
Rupert Bartsch
European Society for Medical Oncology 2020. Memo 14 (2) (2021)

volume 14, number 3, 2021

Eberhard Gunsilius
Interesting news from the annual meeting of the American Society of Hematology 2020. Memo 14 (3) (2021)
Niklas Zojer
SARS-CoV-2 vaccination in patients with solid tumors or hematological malignancies: Is the pandemic over for fully vaccinated patients? Memo 14 (3) (2021)

2020

Mesut Göçer, Erdal Kurtoğlu
Effect of the ABO blood groups on the development, clinical features and survival of multiple myeloma. Memo (2020)
Thorsten Fuereder, Eberhard Gunsilius, Rupert Bartsch, Wolfgang Hilbe, null null
Circumnavigating the challenges of COVID-19 in oncology. Memo (2020)

volume 13, number 3, 2020

Semir Beslija
Managing an oncology clinic during the COVID-19 pandemic-how we did it in Sarajevo? Memo 13 (3) (2020)
Wolfgang Hilbe, Andreas Pircher, Thorsten Füreder, Holger Rumpold, Eberhard Gunsilius, Rupert Bartsch
Creating the "new normal" post-Coronavirus world-web-communication replacing face-to-face interaction. Memo 13 (3) (2020)

volume 12, number 2, 2019

Seray Karagöz Özdemir, Utku Iltar, Ozan Salim, Orhan Kemal Yücel, Ramazan Erdem, Özge Turhan, Levent Undar
Investigation of seasonal frequency and pathogens in febrile neutropenia. Memo 12 (2) (2019)

volume 11, number 3, 2018

Eva K Masel, Gudrun Kreye
Demystification of palliative care: what palliative care teams don't want you to think about them. Memo 11 (3) (2018)
Gabriel Rinnerthaler, Simon Peter Gampenrieder, Richard Greil
SABCS 2017: lifestyle factors, hormone receptor-positive advanced disease, liquid biopsies, and prognosis. Memo 11 (3) (2018)
Matthias Pinter, Wolfgang Sieghart
Long-term remission in advanced stage hepatocellular carcinoma? A chance for cure? Memo 11 (3) (2018)
Rupert Bartsch, Elisabeth Bergen, Arik Galid
Current concepts and future directions in neoadjuvant chemotherapy of breast cancer. Memo 11 (3) (2018)
Rupert Bartsch, Elisabeth Bergen
SABCS 2017: update on chemotherapy, targeted therapy, and immunotherapy. Memo 11 (3) (2018)
Zsuzsanna Bago-Horvath
SABCS 2017 pathology: from bench to bedside. Memo 11 (3) (2018)

volume 11, number 4, 2018

Erika Richtig
ASCO Congress 2018: melanoma treatment. Memo 11 (4) (2018)
Barbara Kiesewetter, Markus Raderer
My burning issues in neuroendocrine tumours (NET). Memo 11 (4) (2018)
Gabriel Rinnerthaler, Simon Peter Gampenrieder, Richard Greil
ASCO 2018 highlights: metastatic breast cancer. Memo 11 (4) (2018)
Rupert Bartsch, Elisabeth Bergen
ASCO 2018: highlights in HER2-positive metastatic breast cancer. Memo 11 (4) (2018)
Gabriele Gamerith, Florian Kocher, Jakob Rudzki, Andreas Pircher
ASCO 2018 NSCLC highlights-combination therapy is key. Memo 11 (4) (2018)
Renate Pichler, Wolfgang Horninger, Isabel Heidegger
ASCO 2018: highlights of urothelial cancer and prostate cancer. Memo 11 (4) (2018)
Fabian Steinkohl, Renate Pichler, Daniel Junker
Short review of biparametric prostate MRI. Memo 11 (4) (2018)